Caris Life Sciences, Inc. 8-K

What Happened

• On May 7, 2026, Caris Life Sciences, Inc. (CAI) announced its financial results for the quarter ended March 31, 2026 by issuing a press release and filing a Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition). The press release was furnished as Exhibit 99.1 to the 8-K.

Key Details

• Filing date: May 7, 2026.
• Reported period: quarter ended March 31, 2026 (Q1 2026).
• Disclosure type: Item 2.02 — results of operations and financial condition; press release furnished as Exhibit 99.1.
• Report signed on behalf of the company by Luke Power, Senior VP, CFO and Chief Accounting Officer.

Why It Matters

• This 8-K signals Caris has publicly released its quarterly earnings information (earnings, revenue and other quarterly results) — material data that can affect investor decisions and the stock price.
• Retail investors should read the furnished press release (Exhibit 99.1) and the company’s subsequent SEC filings (e.g., the quarterly report on Form 10-Q) for the full financial figures, trends, and any management commentary or guidance.